The TRPV3 receptor as a pain target: A therapeutic promise or just some more new biology?

Open Drug Discovery Journal

Volumn 2, Issue SPEC. ISS.2, 2010, Pages 89-97

  Joshi, Neelima Khairatkar ^a   Maharaj, Narendra ^b   Thomas, Abraham ^c  

^a Biological Research   (India)

^b Clinical Research and Development   (India)

^c Glenmark Pharmaceuticals   (India)

Author keywords

2 APB; Heat; Keratinocytes; Pain; TRP channel; TRPV3

Indexed keywords

ANALGESIC AGENT; ARACHIDONIC ACID; DICLOFENAC; GRC 15133; GRC 15300; GRC 15691; GRC 17173; MORPHINE; PROTEIN INHIBITOR; UNCLASSIFIED DRUG; VANILLOID RECEPTOR 1 ANTAGONIST; VANILLOID RECEPTOR 3; VANILLOID RECEPTOR AFFECTING AGENT; VANILLOID RECEPTOR ANTAGONIST;

ANALGESIA; ARTHRALGIA; CALCIUM SIGNALING; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG SAFETY; FEVER; GENE OVEREXPRESSION; HEAT SENSITIVITY; HUMAN; HYPERALGESIA; NEUROPATHIC PAIN; PAIN; PAIN ASSESSMENT; PAIN THRESHOLD; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN SECRETION; PROTEIN TARGETING; REVIEW; SIGNAL TRANSDUCTION; TEMPERATURE SENSITIVITY;

EID: 79961017633     PISSN: None     EISSN: 18773818     Source Type: Journal    
DOI: 10.2174/1877381801002030089     Document Type: Review

References (60)

1. Xu, H.I.; Ramsey, S.; Kotecha, S.A.; Moran M.M.; Chong, J.A.; Lawson, D.; Ge, P.; Lilly, J.; Silos-Santiago, I.; Xie, Y.; DiStefano, P.S.; Curtis, R.; Clapham, D.E. TRPV3 is a calcium-permeable temperature-sensitive cation channel. Nature, 2002, 418, 181-186.
2. Smith, G.D.; Gunthrope, M.J.; Kelsell, R.E.; Hayes, P.D.; Reilly, P.; Facer, P. TRPV3 is a temperature-sensitive vanilloid Receptorlike protein. Nature, 2002, 418, 186-190.
3. Montell, C.; Birnbaumer, L.; Flockerzi, V.; Bindels, R.J.; Bruford, E.A.; Caterina, M.J.; Clapham, D.E.; Harteneck, C.; Heller, S.; Julius, D.; Kojima, I.; Mori, Y.; Penner, R.; Prawitt, D.; Scharenberg, A.M.; Schultz, G.; Shimizu, N.; Zhu, M.X. A unified nomenclature for the superfamily of TRP cation channels. Mol. Cell, 2002, 9, 229-231.
4. Peier, A.M.; Reeve, A.J.; Anderson, D.A.; Moqrich, A.; Earley, T.J.; Hergarden, A.C.; Story, G.M.; Colley, S.; Hogenesch, J.B.; McIntyre, P.; Bevan, S.; Patapoutian, A. A heat-sensitive TRP channel expressed in keratinocytes. Science, 2002, 296, 2046-2049.
5. Chung, M.-K.; Lee, H.; Caterina, M.J. Warm temperatures activate TRPV4 in mouse 308 keratinocytes. J. Biol. Chem., 2003, 278, No.34, 32037-32046.
6. Chung, M.-K.; Lee, H.; Mizuna, A.; Suzuki, M.; Caterina, M.J. TRPV3 and TRPV4 mediate warmth-evoked currents in primary mouse keratinocytes. J. Biol. Chem., 2004, 279, 21569-21575.
7. Moqrich, A.; Hwang, S.W.; Earley, T.J.; Petrus, M.J.; Murray, A.N.; Spencer, K.S.; Andahazy, M.; Story, G.M.; Patapoutian, A. Impaired thermosensation in mice lacking TRPV3, a heat and camphor sensor in the skin. Science, 2005, 307, 1468-1472.
8. Federick, J.; Buck, M.E.; Matson, D.J.; Cortright, D.N. Increased TRPA1, TRPM8 and TRPV2 expression in dorsal root ganglia by nerve injury. Neurogen Corporation, Branford, CT. USA. Biochem. Biophys. Res. Commun., 2007, 358, 1058-1064.
9. Guatteo, E.; Chung, K.K.; Bowala, T.K.; Bernardi, G.; Mercuri, N.B.; Lipski, J. Temperature sensitivity of dopaminergic neurons of the substantia nigra pars compacta: involvement of transient receptor potential channels. J. Neurophysiol., 2005, 94, 3069-3080.
10. Facer, P.; Casula, M.A.; Smith, G.D.; Christopher, D.B.; Iain, P.C.; Chas, B.; Marco, S.; Rolfe, B.; Praveen, A. Differential expression of the capsaicin receptor TRPV1 and related novel receptors TRPV3, TRPV4 and TRPM8 in normal human tissues and changes in traumatic and diabetic neuropathy. BMC Neurol., 2007, 7, 1-12.
11. Mandadi, S.; Roufogalis, B.D. Thermo TRP channels in Nociceptors: taking a lead from Capsaicin Receptor TRPV1. Curr. Pharmacol., 2008, 6, 21-38.
12. Xu, H.; Delling, M.; Jun, J.C.; Clapham, D.E. Oregano, Thyme and clove-derived flavors and skin sensitizers activate specific TRP channels. Nat. Neurosci., 2006, 9, 628-635.
13. Hu, H.-Z.; Gu, Q.; Wang, C.; Colton, C.K.; Tang, J. 2-Aminoethoxydiphenyl borate is a common activator of TRPV1, TRPV2, and TRPV3. J. Biol. Chem., 2004, 279, 35741-35748.
14. Dhaka, A.; Viswanath, V.; Patapoutian, A. TRP ion channels and temperature sensation. Ann. Rev. Neurosci., 2006, 29, 135-161.
15. Brauchi, S.; Orta, G.; Salazar, M.; Rosenmann, E.; Latorre, R. A hot sensing cold recptor: C-terminal domain determines thermosensation in transient receptor potential channels. J. Neurosci., 2006, 26, 4835-4840.
16. Caterina, M.J.; Schumacher, M.A.; Tominaga, M.; Rosen, T.A.; Levine, J.D.; Julius, D. The capsaicin receptor: a heat activated ion channel in the pain pathway. Nature, 1997, 389, 816-824.
17. Tominaga, M.; Caterina, M.J.; Malmberg, A.B.; Rosen, T.A.; Gilbert, H.; Skinner, K.; Raumann, B.E.; Basbaum, A.I.; Julius, D. The cloned capsaicin receptor integrates multiple pain producing stimuli. Neuron, 1998, 21, 532-543.
18. Hwang, S.; Bipsongo, T.; Trevisani, M.; Al-Hayani, A; De Petrocellis, L.; Fezza, F.; Tognetto, M.; Petros, T.J.; Krey, J.F.; Chu, C.J.; Miller, J.D.; Davies, S.N.; Geppetti, P.; Walker, J.M.; Di Marzo, V. An endogenous capsaicin-like substance with high potency at recombinant and native vanilloid VR1 receptors. Proc. Natl. Acad. Sci. USA, 2002, 99, 8400-8405.
19. Watanabe, H.; Davis, J.B.; Smart, D.; Jerman, J.C.; Smith, G.D.; Hayes, P.; Vriens, J.; Cairns, W.; Wissenbach, U.; Prenen, J.; Flockerzi, V.; Droogmans, G.; Benham, C.D.; Nilius, B. Activation of TRPV4 channels (hVRL-2/mTRP12) by phorbol deravatives. J. Biol. Chem., 2002, 277, 13569-13577.
20. Watanabe, H.; Virens, J.; Prenen, J.; Droomans, G.; Voets, T.; Nilius, B. Anandamide and arachidonic acid use epoxyeicosatrienoic acids to activate TRPV4 channels. Nature, 2003, 424, 434-438.
21. Vogt-Eisele, A.K.; Weber, K.; Sherkheli, M.A.; Vielhaber, G.; Panten, J.; Gisselmann, G.; Hatt, H. Monoterpenoid agonists of TRPV3. Br. J. Pharmacol., 2007, 151, 530-540.
22. Clapham, D.E.; Runnels, L.W.; Strubing, C. The TRP ion channel family. Nat. Rev. Neurosci., 2001, 2, 387-396.
23. Clapham, D.E.; Montell, C.; Schultz, G.; Julius, D. International union of pharmacology. XLIII. compendium of voltage-gated ion channels: transient receptor potential channels. Pharmacol. Rev., 2008, 55, 591-596.
24. Dobrydneva, Y.; Blackmore, P. 2-Aminoethoxydiphenyl borate directly inhibits store-operated calcium entry channels in human platelets. Mol. Pharmacol., 2001, 60, 541-552.
25. 2+ release-activated Ca2+ channels by 2-aminoethyldiphenyl borate (2-APB) occurs independently of IP3 receptors J. Physiol. 2001, 536, 3-19.
26. 2+ release. FASEB J. 2002, 16, 11445-1150.
27. Moussaieff, A.; Rimmerman, N.; Bregman, T.; Straiker, A.; Felder, C.C.; Shoham, S.; Kashman, Y.; Huang, S.M.; Lee, H.; Shohami, E.; Mackie, K.; Caterina, M.J.; Walker, J.M.; Fride, E.; Mechoulam, R. Incensole acetate, an incence component, elicits psychoactivity by activating TRPV3 channels in the brain. FASEB J., 2008, 22, 3024-3034.
28. Hu, H.-Z.; Xiao, R.; Wang, C.; Gao, N.; Colton, C.K.; Wood, J.D.; Zhu, M.X. Potentiation of TRPV3 channel function by unsaturated fatty acids. J. Cell Physiol., 2006, 208, 201-212.
29. Hwang, S.; Cho, H.; Kwak, J.; Lee S.Y.; Kang C.J.; Jung J.; Cho S.; Min K.H.; Suh Y.G.; Kim D.; Oh, U. Direct activation of capsaicin receptors by products of lipoxygenases: endogenous capsaicin-like substances. Proc. Natl. Acad. Sci. USA, 2000, 97, 6155-6160.
30. Shin, J.; Cho, H.; Hwang, S.W. Brasykinin-12-lipoxygenase-VR1 signaling pathway for inflammatory hyperalgesia. Proc. Natl. Acad. Sci. USA, 2002, 99, 10150-10155.
31. Hammarstrom, S.; Hamberg, M.; Samuelsson, B.; Duell, E.A.; Stawiski, M.; Voorhees, J.J. Increase concentrations of nonesterified arachidonic acid, 12L-hydroxy-5,8,10,14-eicosatetraenoic acid, prostaglandin E2, and prostaglandin F2alpha in epidermis of psoriasis. Proc. Natl. Acad. Sci. USA, 1975, 72, 5130-5134.
32. Brash, A.R. Arachidonic acid as a bioactive molecule. J. Clin. Invest., 2001, 107, 1339-1345.
33. Jaffrey, S.R.; Erdjument-Bromage, H.; Ferris, C.D.; Tempst, P.; Snyder, S.H. Protein S-nitrosylation: a physiological signal for neuronal nitric oxide. Nat. Cell Biol., 2001, 3, 193-197.
34. Yoshida, T.; Inoue, R.; Morii, T.; Takahashi, N.; Yamamoto, S.; Hara, Y.; Tominaga, M.; Shimizu, S.; Sato, Y.; Mori, Y. Nitric oxide activities TRP channels by cysteine S-nitosylation. Nat. Chem. Biol., 2006, 2, 596-607.
35. Lee, H.; Caterina, M.J. TRPV channels as thermosensory receptors in epithelial cells. Pflugers Arch., 2005, 451, 160-167.
36. Khodorova, A.; Navarro, B.; Jouaville, L.S.; Murphy, J.E.; Rice, F.L.; Mazurkiewicz, J.E.; Long-Woodward, D.; Stoffel, M.; Strichartz, G.R.; Yukhananov, R.; Davar, G. Endothelin-B receptor activation triggers an endogenous analgesic cascade at sites of peripheral injury. Nat. Med., 2003, 9, 1055-1061.
37. Huang, S.M.; Lee, H.; Chung, M.-K.; Park, U.; Yu, Y.Y.; Bradshaw, H.B.; Coulombe, P.A.; Walker, J.M.; Caterina, M.J. Overexpressed transient receptor potential vanilloid 3 ion channels in skin keratinocytes modulate pain sensitivity via prostaglandin E2. J. Neurosci., 2008, 28, 13727-13737.
38. Moriyama, T.; Higashi, T.; Togashi, K.; Iida, T.; Segi, E.; Sugimoto, Y.; Tominaga, T.; Narumiya, S; Tominaga, M. Sensitization of TRPV1 by EP1 and IP reveals peripheral nociceptive mechanism of prostaglandins. Mol. Pain, 2005, 1, 3.
39. Oida, H.; Namba, T.; Sugimoto, Y.; Ushikubi, F.; Ohishi, H.; Ichikawa, A.; Narumiya, S. In situ hybridization studies of prostacyclin receptor mRNA expression in various mouse organs. Br. J. Pharmacol., 1995, 116, 2828-2837.
40. Southall, M.D.; Vasko, M.R. Prostaglandin receptor subtypes, EP3C and EP4, mediate the prostaglandin E2-induced cAMP production and sensitization of sensory neurons. J. Biol. Chem., 2001, 276, 16083-16091.
41. Sugimoto, Y.; Shigemoto, R.; Namba, T.; Negishi, M.; Mizuno, N.; Narumiya, S.; Ichikawa, A. Distribution of the messenger RNA for the prostaglandin E-receptor sub type EP3 in the mouse nervous system. Neuroscience, 1994, 62, 919-928.
42. Yoshika, T.; Imura, K.; Asakawa, M.; Suzuki, M.; Oshima, I.; Hirasawa, T.; Sakata, T.; Horikawa, T.; Arimura, A. Impact of the Gly573Ser substitution in TRPV3 on the development of allergic and pruritic dermatis in mice. J. Invest. Dermatol., 2009, 129, 714-722.
43. Mandadi, S.; Sokabe, T.; Shibasaki, K.; Katanosaka, K.; Mizuno, A.; Moqrich, A.; Patapoutian, A.; Fukumi-Tominaga, T.; Mizumura, K.; Tominaga, M. TRPV3 in keratinocytes transmits temperature information to sensory neurons via ATP. Eur. J. Physiol., 2009, 458, 1093-1102.
44. Xiao, R.; Tang, J.; Wang, C.; Colton, C.K.; Tian, J.; Zhu, M.X. Calcium plays a central role in the sensitization of TRPV3 channel to repetitive stimulations. J. Biol. Chem., 2008, 283, 6162-6174.
45. Bevan, S.; Ganju, P.; McIntyre, P.; Patapoutian, A.; Peier, A.; Song, C. Transient receptor potential channel TRPV3 and its tissue. US Patent 7,396,910 B2, July 8, 2008.
46. Gopinath, P.; Wan, E.; Holdcroft, A.; Paul, F.; John, B.D.; Graham, D.S.; Chas, B.; Praveen, A. Increased capsaicin receptor TRPV1 in skin nerve fibres and related vanilloid receptors TRPV3 and TRPV4 in leratinocytes in human breast pain. BMC Women's Health, 2005, 5, 1-9.
47. Ferreica, S.H.; Nakamura, M.; de Abreu Castro, M.S. The hyperalgesic effects of prostaciclin and prostaglandin E2. Prostaglandins, 1978, 16, 31-37.
48. Imura, K.; Yoshioka, T.; Hirasawa, T.; Sakata, T. Role of TRPV3 in immune response to development of dermatis. J. Inflamm., 2009, 6, 1-10.
49. Maruyama, K.; Zhang, J.-Z.; Nihei, Y.; Ono, I.; Kaneko, F. Regulatory effects of antipsoriatic agents on interleukin-1 production by human keratinocytes stimulated with gamma interferon in vitro. Skin Pharmacol., 1995, 8(1-2), 41-48.
50. Chung, M.K.; Guler, A.D.; Caterina, M.J. Biphasic currents evoked by chemical or thermal activation of the heat-gated in channel, TRPV3. J. Biol. Chem., 2005, 280, 15928-15941.
51. Chong, J.; Fanger, C.; Larsen, G.R.; Lumma Jr., William C.; Mahadevan, A.; Meltzer P.; Moran, M.M.; Ripka, A.U.; Dennis, J.; Weigele M.; Zhen, X. Compounds for modulating TRPV3 Function. WO 2007/056124 A2, May 18, 2007.
52. Chong, J.; Fanger, C.; Moran, M.; Underwood, D.J.; Zhen, X.; Ripka, A. Compounds for Modulating TRPV3 Function. WO 2006/122156 A2, November 16, 2006.
53. Hydra Biosciences and Pfizer global research & Development Sign collaboration agreement. Leverages Hydra's Proprietary Ion Channel Technology in the area of pain. Cambridge, MA, July 26, 2007. Available at: www.hydrabiosciences.com/pdf/press_releases/2007_07_26.pdf
54. Gullapalli, S. GRC 15133 is a TRPV3 selective antagonist with moderate antagonistic potency. World Pharmaceutical Congress, Philadelphia, PA, USA, May 12-13, 2008.
55. Joshi, N.K. TRPV3 Antagonist in Pain Management - Generation Next?. SMi 8th Annual conference - Pain Therapeutics. Copthorne, London, June 9-10, 2008.
56. Glenmark Pharmaceuticals Limited. Biological Research. http://www.glenmarkpharma.com
57. Imura, K.; Yoshioka, T.; Hikita, I.; Tsukahara, K.; Arimura, A.; Sakata, T. Influence of TRPV3 mutation on hair growth cycle in mice. Biochem. Biophys. Res. Commun., 2007, 363, 479-483.
58. Asakawa, M.; Yoshioka, T.; Matsutani, T.; Hikita, I.; Suzuki, M.; Oshima, I.; Tsukahara, K.; Arimura, A.; Horikawa, T.; Hirasawa, T.; Sakata, T. Association of a mutation in TRPV3 with defective hair growth in rodents. J. Investig. Dermatol., 2006, 126, 2664-2672.
59. Steiner, A.A.; Turek, V.F.; Almeida, M.C.; Burmeister, J.J.; Oliveira, D.L.; Roberts, J.L.; Bannon, A.W.; Norman, M.H.; Louis, J.C.; Treanor, J.J.; Gavva, N.R.; Romanovsky, A.A. Nonthermal activation of transient receptor potential vanilloid-1 channels in abdorminal viscera tonically inhibits autonomic cold-defence effectors. J. Neurosci., 2007, 27, 7459-7468.
60. Crutchlow, M. Merck Research Laboratories. Pharmacologic Inhibition of TRPV1 impairs sensation of potentially injurious heat in healthy subjects. ASCPT 2009 in Gaylord National Resort & Convention Centre on the Potomac, National Habour, Maryland, March 18-21, 2009.